142 related articles for article (PubMed ID: 36089548)
1. Impact of the SARS-CoV-2 pandemic on the diagnosis of primary cutaneous melanoma at a University Hospital in Rio de Janeiro.
Barcaui CB; Machado CJ; Piñeiro-Maceira J
An Bras Dermatol; 2022; 97(6):801-803. PubMed ID: 36089548
[No Abstract] [Full Text] [Related]
2. Impact of the COVID-19 pandemic on melanoma diagnosis.
Gisondi P; Cazzaniga S; Di Leo S; Piaserico S; Bellinato F; Pizzolato M; Gatti A; Eccher A; Brunelli M; Saraggi D; Girolomoni G; Naldi L
J Eur Acad Dermatol Venereol; 2021 Nov; 35(11):e714-e715. PubMed ID: 34236721
[No Abstract] [Full Text] [Related]
3. Comment on "The impact of the COVID-19 pandemic on the presentation status of newly diagnosed melanoma: A single institution experience".
McFeely O; Hollywood A; Stanciu M; O'Connell M; Paul L
J Am Acad Dermatol; 2021 Dec; 85(6):e419-e420. PubMed ID: 34464625
[No Abstract] [Full Text] [Related]
4. Impact of the SARS-CoV-2 pandemic on the early diagnosis of melanoma.
Fernández Canedo MI; de Troya Martín M; Rivas Ruíz F
Med Clin (Barc); 2021 Apr; 156(7):356-357. PubMed ID: 33618835
[No Abstract] [Full Text] [Related]
5. Impact of COVID-19 pandemic on health equality in malignant melanoma diagnosis.
Lun LK; Cheng H; Hussain R
Clin Med (Lond); 2023 Nov; 23(Suppl 6):62. PubMed ID: 38182253
[No Abstract] [Full Text] [Related]
6. Space-time analysis of the first year of COVID-19 pandemic in the city of Rio de Janeiro, Brazil.
Santos CVBD; Cavalcante JR; Pungartnik PC; Guimarães RM
Rev Bras Epidemiol; 2021; 24():e210046. PubMed ID: 34730708
[TBL] [Abstract][Full Text] [Related]
7. Delayed skin cancer diagnosis in 2020 because of the COVID-19-related restrictions: Data from an institutional registry.
Lallas A; Kyrgidis A; Manoli SM; Papageorgiou C; Lallas K; Sotiriou E; Vakirlis E; Sidiropoulos T; Ioannides D; Apalla Z
J Am Acad Dermatol; 2021 Sep; 85(3):721-723. PubMed ID: 34052332
[TBL] [Abstract][Full Text] [Related]
8. Delayed Metastatic Polypoid Nodular Melanoma Diagnosis During COVID-19 Pandemic, Successful Treatment With Surgery and Nivolumab.
Bradu S; Siegel D; Loyal J; Leaf A; Kurtti A; Alapati U; Jagdeo J
J Drugs Dermatol; 2021 Dec; 20(12):1343-1345. PubMed ID: 34898148
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic Delays for Non-melanoma Skin Cancers in Renal Transplant Recipients during the COVID-19 Pandemic: What is Hiding Behind the Mask?
Mokos M; Bašić-Jukić N
Acta Dermatovenerol Croat; 2021 Jul; 29(2):111-113. PubMed ID: 34477079
[TBL] [Abstract][Full Text] [Related]
10. Heterogeneity of reports about the impact of the COVID-19 pandemic on melanoma diagnosis.
Ricci F; Abeni D
Br J Dermatol; 2022 Aug; 187(2):135-136. PubMed ID: 35610054
[No Abstract] [Full Text] [Related]
11. Impact of COVID-19 on melanoma diagnosis.
Weston GK; Jeong HS; Mu EW; Polsky D; Meehan SA
Melanoma Res; 2021 Jun; 31(3):280-281. PubMed ID: 33625106
[No Abstract] [Full Text] [Related]
12. The impact of the COVID-19 pandemic on the diagnosis of cutaneous melanomas: A retrospective cohort study from five European skin cancer reference centres.
Troesch A; Hoellwerth M; Forchhammer S; Del Regno L; Lodde G; Turko P; Cheng PF; Levesque ML; Hadaschik E; Livingstone E; Peris K; Flatz L; Koelblinger P; Dummer R; Dimitriou F
J Eur Acad Dermatol Venereol; 2023 May; 37(5):922-931. PubMed ID: 36785973
[TBL] [Abstract][Full Text] [Related]
13. Impact of COVID-19 pandemic on melanoma presentation by facility type and region in the United States.
Kim DY; Behbahani S; Hartman RI
J Am Acad Dermatol; 2023 Jul; 89(1):175-178. PubMed ID: 36898529
[No Abstract] [Full Text] [Related]
14. A Reminder of Skin Cancer During the COVID-19 Pandemic.
Šitum M; Filipović N; Buljan M
Acta Dermatovenerol Croat; 2021 Apr; 291(1):58. PubMed ID: 34477068
[TBL] [Abstract][Full Text] [Related]
15. COVID-19 and melanoma surgery in a dermo-oncology centre in Italy.
Dika E; Barisani A; Baraldi C; Pepe F; Patrizi A; Vaccari S
Clin Exp Dermatol; 2021 Aug; 46(6):1134. PubMed ID: 33837580
[No Abstract] [Full Text] [Related]
16. High prevalence of SARS-CoV-2 infection among symptomatic healthcare workers in a large university tertiary hospital in São Paulo, Brazil.
Buonafine CP; Paiatto BNM; Leal FB; de Matos SF; de Morais CO; Guerra GG; Martuchelli MVV; Oliveira DBL; Durigon EL; Soares CP; Candido ED; Telezynski BL; Sáfadi MAP; Almeida FJ
BMC Infect Dis; 2020 Dec; 20(1):917. PubMed ID: 33267836
[TBL] [Abstract][Full Text] [Related]
17. A significant reduction in the diagnosis of melanoma during the COVID-19 lockdown in a third-level center in the Northern Italy.
Barruscotti S; Giorgini C; Brazzelli V; Vassallo C; Michelerio A; Klersy C; Chiellino S; Tomasini CF
Dermatol Ther; 2020 Nov; 33(6):e14074. PubMed ID: 32713046
[No Abstract] [Full Text] [Related]
18. Missing melanomas in England during the COVID-19 pandemic: 2485 fewer melanoma diagnoses in 2020 than in 2019.
Ibrahim LS; Venables ZC; McPhail S; Levell NJ
Br J Dermatol; 2023 Aug; 189(3):345-347. PubMed ID: 37032445
[No Abstract] [Full Text] [Related]
19. The impact of the COVID-19 pandemic in 2020 on the diagnosis, treatment, and outcomes of invasive cutaneous melanoma: A retrospective national cohort study.
Xiong DD; Bordeaux J
J Am Acad Dermatol; 2023 Dec; 89(6):1167-1176. PubMed ID: 37625699
[TBL] [Abstract][Full Text] [Related]
20. Study of 448 cases of melanoma in situ in two hospitals in Rio de Janeiro.
Pantaleão L; Rochael MC
An Bras Dermatol; 2017; 92(2):277-278. PubMed ID: 28538900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
